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SUMMARY
This study aimed to determine the seroprevalence of Kaposi’s sarcoma-associated herpesvirus
(KSHV) and related factors in men who have sex with men (MSM) in China. A total of 208
subjects were recruited from eastern China from 2008 to 2009. Plasma samples were collected and
screened for KSHV, HIV and syphilis. Overall, KSHV seroprevalence was 32.7 % in the subjects.
About 92.7 % of subjects reported having ever had anal sex with a man, of whom 67.8 % had
receptive anal sex and 77.9 % had insertive anal sex. About 93.1 % of the study participants
reported having had oral sex with a man, of whom 76.0 % had receptive oral sex and 56.7% had
insertive oral sex. KSHV seropositivity was independently associated with receptive anal sex
[odds ratio (OR) 2.68, 95% conﬁdence interval (CI) 1.15–6.23], syphilis (OR 3.25, 95 % CI
1.56–6.76) and HSV-2 infection (OR 2.40, 95 % CI 1.09–5.26). KSHV infection is highly
prevalent and is probably sexually transmitted among MSM in eastern China.
Key words: China, men who have sex with men, Kaposi’s sarcoma-associated herpesvirus,
prevalence.

INTRODUCTION
Kaposi’s sarcoma-associated herpesvirus (KSHV),
also known as human herpesvirus-8 (HHV-8), is
the aetiological agent linked to Kaposi’s sarcoma,
primary eﬀusion lymphoma and multicentric
Castleman’s disease [1]. Since its initial discovery,
KSHV infection has been reported with seroprevalence and risk factors exhibiting considerable
variations across diﬀerent geographical regions [2, 3].

* Author for correspondence : Professor N. He, M. D., Ph.D.,
Department of Epidemiology, School of Public Health, Fudan
University, Shanghai 200032, PR China.
(Email : nhe@shmu.edu.cn)
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Men who have sex with men (MSM) were ﬁrst reported to be at high risk for developing Kaposi’s sarcoma in the 1980s [4]. North America and Europe are
regions with low KSHV seroprevalence in the general
population but high prevalence of KSHV infection in
the MSM population, especially in those co-infected
with HIV [5–7]. It is now well established that MSM
are at a higher risk for acquiring KSHV infection although the deﬁnite routes of KSHV transmission
have yet to be established [8, 9]. Based on previous
reports, KSHV appears to be sexually transmitted in
MSM, although the extent of sexual transmission in
heterosexuals is less certain [10–14].
In general, China is regarded as a region of low
KSHV prevalence due to an apparent lack of
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Kaposi’s sarcoma development, except for the
Xinjiang Uygur Autonomous Region in the west of
the country [15, 16]. However, a seroprevalence study
conducted in central China showed that KSHV
prevalence was as high as 15.8 % in a HIV-positive
group [17]. Although MSM have already been found
to be a high-risk group for HIV and sexually transmitted infections (STIs) in China [18], there is
no available information on KSHV infection in
this population. It is estimated that approximately
18 million MSM reside in China. Given the large size
of the MSM population and its potential impact on
the HIV epidemic, this population will not only be
at risk of increasing morbidity due to AIDS-related
diseases in the near future, but could also be a
potential source of transmission of KSHV infection
to the heterosexual population, as seen in the early
phases of the HIV epidemic.
To address this gap in the available literature, a
cross-sectional study was performed to investigate the
prevalence and correlates of KSHV infection in MSM
in Taizhou, a rural area in eastern China where the
HIV/AIDS epidemic is rapidly spreading in the MSM
population.
MATERIAL AND METHODS
Study population
The present study was conducted in the MSM population in Taizhou prefecture, Zhejiang province in
eastern China.
Given the diﬃculty of approaching the MSM
population in rural areas in China, a combined sampling strategy using both venue-based sampling and
snowball sampling was applied for subject recruitment. To be eligible, a study participant had to be a
male who : (1) was aged o18 years, (2) acknowledged
ever having had sex with another man, and (3) provided written informed consent for participation.
During the 1-year study period from December 2008
to December 2009, a total of 239 MSM were approached, of whom 208 (87.0 %) agreed to participate
in this study. This study was approved by the
Institutional Review Board of Fudan University,
Shanghai, China.
Data and sample collection
A structured questionnaire, aimed at obtaining information about socio-demographic characteristics
and sexual behaviours, was developed from validated

data collection instruments previously reported in the
literature. Face-to-face interviews were administered
by trained public health workers.
Venous blood was drawn and transferred to the
laboratory within 2 h after collection. Plasma samples
were coded with a unique identiﬁer, and stored at
x80 xC until testing.

Serological testing
HIV testing
All plasma samples were screened for HIV antibodies
using an enzyme-linked immunosorbent assay
(ELISA ; Abbott Laboratories, USA), according to
the manufacturer’s instructions. Positive samples
were conﬁrmed by Western blotting (Genelabs
Diagnostic, Singapore).
KSHV testing
Plasma samples were tested by immunoﬂuoresence
assay, as reported previously [19]. Brieﬂy, two KSHV
serology tests were performed : ﬁrst, BC-3 cells
(KSHV-positive and Epstein–Barr virus-negative B
cell line ; American Type Culture Collection, USA),
stimulated by tetradecanoyl phorbol acetate
were ﬁxed and permeabilized and used for monoclonal enhanced immunoﬂuorescence assay. Second,
Spodoptera frugiperda clone 9 expressing viral recombinant proteins, ORF73, ORF65 and ORF-K8.1,
was used for testing. The procedure was similar to the
BC-3 immunoﬂuoresence assay. A sample was considered KSHV seropositive only if it was positive at a
standard serum dilution of 1 :40 with both the BC-3
and S. frugiperda assay. Each slide was read independently by two experienced laboratory workers.
Syphilis testing
Plasma samples were tested using a rapid plasma reagent test (Span Diagnostics Ltd, India), and results
were conﬁrmed by the Treponema pallidum haemagglutination test (TPHA; Syphagen TPHA, Biokit,
Spain) for diagnosis of syphilis.
Other serological testing
All plasma samples were also tested with ELISA
for the presence of IgG antibodies to hepatitis C
virus (HCV) (Wantai Bio Co., China), IgG antibodies
to herpes simplex virus-2 (HSV-2) (HerpeSelect
ELISA kit, Focus Technologies, USA), and hepatitis
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B surface antigen (Wantai Bio Co.), according to the
manufacturers’ instructions.
All the above serological tests were performed by
two experienced technicians, with duplicate negative,
positive and blank controls being tested in parallel.
Statistical analysis
Original questionnaires and laboratory testing results
were managed in EpiData3.0 (EpiData Association,
Denmark), and transferred to a statistical analysis
system (SAS Institute Inc., USA) database for further
analyses. Demographic characteristics and risk behaviours were analysed using descriptive statistics,
i.e. mean, median and interquartile range (IQR) for
continuous variables, and proportions for categorical
variables.
KSHV seroprevalence was computed using the
normal approximation, and tabulated by sociodemographic characteristics of the study subjects,
followed by Pearson’s x2 test to determine statistical
signiﬁcance. Initially, univariate logistic regression
analysis was conducted, followed by multivariate
logistic regression analysis to explore associations
between sexual behaviours and KSHV seropositivity.
Odds ratio (OR) and 95 % conﬁdence interval
(CI) were used to determine whether a variable was
associated with KSHV infection. Mann–Whitney U
test was used to assess the diﬀerence of geometric
mean titres (GMTs) of anti-KSHV IgG between the
KSHV mono-infection group and the co-infection
group. A P value f0.05 was considered to be statistically signiﬁcant. All statistical analyses were performed using the SAS System for Windows version
8.0 (SAS Institute Inc.).
RESULTS
Characteristic and KSHV seroprevalence in
participants
A total of 208 MSM participated in this study.
Sociodemographic characteristics of the participants
are summarized in Table 1. Brieﬂy, the median age of
the participants was 26 years (IQR 23–31 years).
About 78.4 % of the participants were non-sex
workers (referred to as ‘general MSM ’) and the other
21.6% were male sex workers known as ‘money
boys ’ who provided commercial sex to other men.
Approximately 48.1 % of the study participants were
self-identiﬁed homosexual men, 28.8 % were bisexual
and 23.1 % were unsure of their sexual orientation.
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The overall seroprevalence of KSHV was 32.7 %
(68/208) in study participants. KSHV seroprevalence
was signiﬁcantly higher in those who were ever
married compared to those who were never married,
but the prevalence did not diﬀer signiﬁcantly
based on other sociodemographic characteristics
(Table 1).
Association of KSHV prevalence with sexual practices
Table 2 summarizes the prevalence of diﬀerent sexual
practices of the study participants and the association
of KSHV prevalence with these practices. About
76.9% of study participants reported having had sex
with women. The proportion reporting heterosexual
behaviour was 67.6% in those never married, 97.0 %
in those ever married, 79.1% in ‘general MSM ’ and
68.9% in ‘money boys’. Of those who had sex with
women, 55.0% had heterosexual contact in the past
month. However, only 38.6 % had always used condoms whereas 39.7 % had never used condoms during
these heterosexual practices. About 92.7 % (193/208)
of study participants reported having had anal sex
with a man, of whom 67.8% reported receptive anal
sex and 77.9% reported insertive anal sex. About
89.4% of study participants reported having had anal
sex with men in the past month. Of these, 41.9 % had
regularly used condoms.
About 93.1% of study participants reported having
had oral sex with a man, 76.0 % had receptive oral sex
and 56.7 % had insertive oral sex. About 91.3% of
study participants reported having had oral sex with
man in the past month. Of these, only 17.3 % (33/190)
had regularly used condoms.
Univariate analyses indicated that KSHV infection
was signiﬁcantly associated with anal sex with a man
(Table 2). Those who had high frequency of anal sex
with a man in the past month, did not use condoms
for anal sex in the past month, and had ever had
receptive anal sex with a man were more likely to be
infected with KSHV. After adjusting for sociodemographic variables including MSM group category, age and marital status by multivariate logistic
regression analyses, having ever had receptive anal sex
with a man was still signiﬁcantly associated with
KSHV infection (OR 2.68, 95% CI 1.15–6.23).
Whereas high frequency of anal sex with a man in the
past month was associated with KSHV infection only
at the marginal signiﬁcance level (Table 2). KSHV
infection was not signiﬁcantly associated with sex
with a woman and oral sex with a man (Table 2).
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Table 1. Sociodemographic characteristics, sexual orientation and KSHV infection in study participants
KSHV infection

MSM group category
General MSM
Sex workers (i.e. ‘money boys ’)
Residency
Local
Non-local
Age (years)
18–20
21–25
26–30
31–58
Marital status
Never married
Ever married
Education
Middle school
High school
College
Sexual orientation
Homosexual only
Bisexual
Not sure

No. (%)*

No. of
positives (%)#

OR (95 %CI)$

P value

163 (78.4)
45 (21.6)

52 (31.9)
16 (35.6)

1.00
1.18 (0.59–2.35)

0.644

104 (50.0)
104 (50.0)

38 (36.5)
30 (28.8)

1.00
0.70 (0.39–1.26)

0.238

22 (10.5)
68 (32.7)
64 (30.8)
54 (26.0)

6 (27.3)
19 (27.9)
24 (37.5)
19 (35.2)

1.00
1.03 (0.35–3.04)
1.60 (0.55–4.64)
1.45 (0.49–4.31)

0.951
0.388
0.507

142 (68.3)
66 (31.7)

40 (28.2)
28 (42.4)

1.00
1.87 (1.02–3.46)

0.043

67 (32.2)
83 (39.9)
58 (27.9)

26 (38.8)
29 (34.9)
13 (22.4)

1.00
0.85 (0.44–1.65)
0.46 (0.21–1.00)

0.625
0.051

100 (48.1)
60 (28.8)
48 (23.1)

37 (37.0)
17 (28.3)
14 (29.2)

1.00
0.67 (0.34–1.35)
0.70 (0.33–1.47)

0.263
0.349

KSHV, Kaposi’s sarcoma-associated herpesvirus ; OR, Odds ratio ; CI, conﬁdence interval ; MSM, men who have sex
with men.
* Proportion.
# Prevalence of KSHV infection.
$ Unadjusted ORs and 95 % CIs obtained from univariate logistic regression analyses.

Other co-infections and association with KSHV
infection
The overall seroprevalence in study participants was
4.3 % for HIV, 16.3 % for HBV (i.e. HBsAg), 1.0 %
for HCV, 18.3% for HSV-2 and 22.1 % for syphilis
(Table 3). The overall prevalence of infection with at
least one of the ﬁve examined infectious agents
was 61.5% for study participants, 57.1% (80/140)
for KSHV-positive participants and 44.1 % (30/68)
for negative participants, but the diﬀerence was not
signiﬁcant (P=0.078).
Univariate logistic regression analyses indicated
that both HSV-2 and syphilis infections were signiﬁcantly associated with KSHV infection. Those who
were infected with HSV-2 (OR 2.82, 95% CI
1.38–5.79) or syphilis (OR 3.29, 95 % CI 1.67–6.48)
were more likely to be infected with KSHV. Such associations were still signiﬁcant after adjusting for potential confounders (Table 3), whereas, no statistically
signiﬁcant association between KSHV infection and
HIV or HBV infections were detected.

To better explore how KSHV antibody titre was
inﬂuenced by these co-infections, plasma from all
KSHV-seropositive subjects was serially diluted
and tested for anti-KSHV IgG antibody titre (Fig. 1).
The GMT of the antibody was 613.3 (95 % CI
366.7–860.0) for the KSHV-only infection group
(n=33) and 562.3 (95 % CI 413.0–711.5) for the coinfection group (n=35). The diﬀerence in the GMT of
the antibody between the KSHV-only infection group
and the co-infection groups was not signiﬁcant
(Mann–Whitney U=488.5, P=0.254).

DISCUSSION
The epidemiology of KSHV infection depicting
speciﬁc demographic pockets of endemicity has long
been puzzling [8, 9]. However, several studies have
reported that MSM is a high-risk group for KSHV
infection [11, 13, 20–23]. It is estimated that HIV
infection in Chinese MSM has reached approximately
5 % [24]. However, social stigma in China makes

Table 2. Sexual behaviours and their associations with KSHV infection in study participants
Sexual behaviour

No. KSHV
infection (%)#

OR (95 % CI)

P value

OR (95 % CI)$

P value$

48 (23.1)
160 (76.9)

15/48 (31.3)
53/160 (33.1)

1.00
1.09 (0.55–2.18)

0.808

0.70 (0.26–1.86)

0.473

35 (16.8)
92 (44.2)
81 (38.9)

4/35 (11.4)
37/92 (40.2)
27/81 (33.3)

1.00
5.21 (1.69–16.01)
3.87 (1.24–12.11)

0.004
0.020

1.00
3.85 (0.96–12.85)
3.05 (0.98–10.51)

0.057
0.135

100 (48.1)
92 (44.2)
16 (7.7)

28/100 (28.0)
30/92 (32.6)
10/16 (62.5)

1.00
1.24 (0.67–2.31)
4.28 (1.42–12.90)

0.488
0.010

1.00
0.82 (0.39–1.73)
3.13 (0.84–11.57)

0.605
0.088

67 (32.2)
141 (67.8)

14/67 (20.9)
54/141 (38.3)

1.00
2.35 (1.19–4.64)

0.014

1.00
2.68 (1.15–6.23)

0.023

46 (22.1)
162 (77.9)

10/46 (21.7)
58/162 (35.8)

1.00
2.01 (0.93–4.34)

0.076

1.55 (0.59–4.08)

0.371

45 (21.6)
84 (40.4)
79 (38.0)

10/45 (22.2)
31/84 (36.9)
27/79 (34.2)

1.00
2.05 (0.89–4.69)
1.82 (0.78–4.22)

0.091
0.165

1.00
1.48 (0.48–4.63)
1.34 (0.41–4.34)

0.494
0.626

51 (24.5)
71 (34.1)
86 (41.3)

17/51 (33.3)
26/71 (36.6)
25/86 (29.1)

1.00
1.15 (0.54–2.46)
0.82 (0.39–1.72)

0.708
0.601

1.00
1.01 (0.29–2.01)
0.57 (0.23–1.48)

0.584
0.249

50 (24.0)
158 (76.0)

16/50 (32.0)
52/158 (32.9)

1.00
1.04 (0.53–2.06)

0.905

1.00
1.01 (0.43–2.35)

0.984

90 (43.3)
118 (56.7)

30/90 (33.3)
38/118 (32.2)

1.00
0.95 (0.53–1.70)

0.863

1.00
0.91 (0.44–1.87)

0.786
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* Proportion.
# Seroprevalence of KSHV.
$ OR and 95 % CI adjusted for sociodemographic characteristics including MSM group category, age, and marital status as shown in Table 1.
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Ever had sex with woman
No
Yes
Frequency of anal sex with man in the past month
0–1
2–5
>6
Condom use for anal sex with man in the past month
Always or no anal sex
Sometimes
Never
Ever had receptive anal sex with man
No
Yes
Ever had insertive anal sex with man
No
Yes
Frequency of oral sex with man in the past month
0–1
2–5
>6
Condom use for oral sex with man in the past month
Always or no anal sex
Sometimes
Never
Ever had receptive oral sex with man
No
Yes
Ever had insertive oral sex with man
No
Yes

No. (%)*
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Table 3. Serostatus of HIV, HBsAg, HCV, syphilis and HSV-2 and their associations with KSHV infection in
study participants
Co-infection
HIV
No
Yes
HBsAg
No
Yes
HCV
No
Yes
HSV-2
No
Yes
Syphilis
No
Yes

No. (%)*

No. KSHV
infection (%)#

OR (95 % CI)

P value

OR (95 % CI)$

P value$

199 (95.7)
9 (4.3)

66 (32.2)
2 (22.2)

1.00
0.58 (0.12–2.85)

0.499

1.00
0.55 (0.10–3.12)

0.498

174 (83.7)
34 (16.3)

56 (32.2)
12 (35.3)

1.00
1.15 (0.53–2.48)

0.724

1.00
1.28 (0.53–3.12)

0.584

206 (99.0)
2 (1.0)

68 (33.0)
0 (0.0)

—
—

—

—
—

—

170 (81.7)
38 (18.3)

48 (28.2)
20 (52.6)

1.00
2.82 (1.38–5.79)

0.005

1.00
2.40 (1.09–5.26)

0.029

162 (77.9)
46 (22.1)

43 (26.5)
25 (54.3)

1.00
3.29 (1.67–6.48)

0.001

1.00
3.25 (1.56–6.76)

0.002

KSHV, Kaposi’s sarcoma-associated herpesvirus ; OR, Odds ratio ; CI, conﬁdence interval.
* Proportion or seroprevalence of HIV, HBsAg, HCV, HSV2 or syphilis, respectively.
# Seroprevalence of KSHV.
$ OR and 95 % CI adjusted for sociodemographic characteristics including MSM group category, age, and marital status as
shown in Table 1.

10000

KSHV antibody titre

P = 0.254

1000

100

10
Mono-KSHV

Co-infection

KSHV co-infection status

Fig. 1. Anti-Kaposi’s sarcoma-associated herpesvirus
(KSHV) IgG antibody titre in patients with KSHV monoinfection vs. patients with KSHV and other co-infections.

MSM very hard to reach, thus very little information
about KSHV infection is available in this population.
In addition, unlike in Western countries, most MSM
in China are also bisexual, married and have families.
Therefore, they are very likely to be a potential source
of transmission of STIs to the heterosexual population. To the best of our knowledge, the present

study is the ﬁrst to report the seroprevalence and
factors associated with KSHV infection in MSM in
China.
The present study identiﬁed a high seroprevalence
of KSHV infection in a sample of Chinese MSM,
suggesting that MSM in China is also a high-risk
group of KSHV infection, as documented by studies
on MSM in other countries [11, 14]. Furthermore, a
substantial proportion of MSM reported heterosexual behaviours regardless of their stated sexual
orientation, and a high KSHV infection rate in evermarried subjects was detected. This implies bisexually
active men in China could potentially play a critical
bridging role in spreading KSHV from their high-risk
male sexual partners to low-risk female partners,
which may explain a heterosexual transmission route
of KSHV.
To further investigate the possible transmission
mechanisms of KSHV in this population, we analysed
the association between KSHV seropositivity and
speciﬁc sexual practices. Receptive anal intercourse
was consistently identiﬁed as a risky sexual practice
for KSHV seropositivity. The association between
KSHV infection and receptive anal intercourse supports the premise that KSHV is sexually transmitted
in MSM [11]. In contrast, oral sex practice was not

KSHV prevalence in Chinese MSM
found to be a risk factor for KSHV seropositivity in
this study. It is, therefore, unlikely that oral genital
sex and oral pharyngeal exposure to semen is a common mechanism of KSHV transmission in this MSM
population. Our results are generally consistent with
previous studies of KSHV in homosexual men in
Western countries [11, 25, 26].
Co-infection with multiple infectious agents is a
common phenomenon in the MSM population, and
a high co-infection rate was detected in both KSHV
positive and negative groups (57.1% vs. 44.1 %, respectively). Moreover, no statistically signiﬁcant
diﬀerence in the GMT of antibody was obtained between KSHV mono-infected and co-infected individuals, suggesting that co-infections may not
have a substantial eﬀect on KSHV antibody titre.
Interestingly, only two HCV-positive subjects, with
none from the KSHV-positive group, were detected.
HCV prevalence (0.9%) is quite low compared to
syphilis prevalence in these MSM subjects. Although
this low prevalence of HCV infection precluded
further meaningful analysis of transmission routes
associated with bloodborne mode, these data nevertheless indicate that MSM are at high risk for STIs
but not for bloodborne infections. This supports our
former study in a community with high risk of
bloodborne infections, particularly HCV, demonstrating that KSHV and HCV might not share the
same transmission routes in that population [17].
Furthermore, HSV-2 and syphilis infections were
found to be positively associated with KSHV seropositivity in this MSM population. Since both HSV-2
and syphilis are mainly sexually transmitted, these
ﬁndings are consistent with data from previous
studies, implying that HSV-2, syphilis and KSHV
may share similar transmission routes [10, 27, 28].
Interestingly, HIV was not found to be associated
with KSHV infection in this study. It is well known
that Kaposi’s sarcoma is linked to AIDS, and KSHV
infection has been found to be strongly associated
with HIV infection [29–31]. However, correlation between KSHV and HIV infection in study participants
was not observed. A possible explanation is that
HIV prevalence in MSM participants in most other
studies was very high, whereas HIV prevalence in
participants in the present study was relatively low.
Nevertheless, our results suggest that KSHV infection
and transmission may have already occurred prior
to the introduction of HIV into this population. It
is possible that sexual practices rather than HIV
infection or associated immunosuppression may be
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risk factors associated with KSHV infection, at least
in our study subjects. Given the close relationship
between HIV and KSHV infections, it is plausible
that a well-designed cohort will be needed to further
investigate the association of HIV and KSHV infections in the MSM population in China.
There are two potential limitations in the current
study. First, we did not compare KSHV seroprevalence between MSM and the general male
population. Nevertheless, a systematic review showed
that KSHV seroprevalence is generally low in males in
eastern China [32]. Second, a potential selection bias
was introduced by using non-random venue-based
and snowball sampling strategies for subject recruitment. Therefore, our study results may not be representative of the whole MSM population in China,
which warrants large-scale study in the near future.
In conclusion, the present study is the ﬁrst epidemiological study of KSHV infection in MSM in
China, and provides evidence that KSHV is highly
prevalent and very likely to be sexually transmitted,
especially through receptive anal sex in this population. Given the high seroprevalence of KSHV in
Chinese MSM and its potential for development of
Kaposi’s sarcoma, further large and longitudinal
epidemiological studies, speciﬁcally designed to identify risk factors for KSHV in MSM in China will be of
substantial public health interest.
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